Collectively, our study reveals the potential of targeting IL8 signaling pathway in improving the therapeutic effect of chemotherapy resistance and transforming prognosis, providing new insights for the selection of treatment strategies for patients with advanced GC. The gene discussed is CXCL8; the disease is gastric cancer.